Spontaneous tension hemothorax in a severe COVID-19 patient receiving ECMO therapy: The other side of COVID-19-associated coagulopathy

As opposed to widely recognized Coronavirus Disease 2019 (COVID-19)-associated thrombotic events, the unusual but serious bleeding complications in COVID-19 patients are worth-mentioned. Here, we describe a 44-year-old man afflicted by COVID-19 pneumonia with acute respiratory distress syndrome (ARD...

Descripción completa

Detalles Bibliográficos
Autores principales: Thammavaranucupt, Kanin, Tassaneyasin, Tanapat, Theerawit, Pongdhep, Sutherasan, Yuda, Pinsem, Pimwatana, Suppadungsuk, Supawadee, Nanthatanti, Nithita, Kirdlarp, Suppachok, Sungkanuparph, Somnuek, Srichatrapimuk, Sirawat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072841/
https://www.ncbi.nlm.nih.gov/pubmed/35559365
http://dx.doi.org/10.1016/j.rmcr.2022.101663
Descripción
Sumario:As opposed to widely recognized Coronavirus Disease 2019 (COVID-19)-associated thrombotic events, the unusual but serious bleeding complications in COVID-19 patients are worth-mentioned. Here, we describe a 44-year-old man afflicted by COVID-19 pneumonia with acute respiratory distress syndrome (ARDS) and submassive pulmonary embolism. The patient's condition initially improved with the prescription of ECMO, tocilizumab, and hemoadsorption, however, he later developed spontaneous tension hemothorax, which is considered rare but devastating in the setting of COVID-19. While the exact pathogenesis of COVID-19-associated bleeding events remains poorly understood, we aim to highlight the other aspect of coagulation dysfunction potentially caused by COVID-19.

Ejemplares similares